WallStreetZenWallStreetZen

NASDAQ: CKPT
Checkpoint Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CKPT past revenue growth

How has CKPT's revenue growth performed historically?
Company
-46.35%
Industry
145.73%
Market
17.2%
CKPT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CKPT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CKPT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CKPT earnings and revenue history

Current Revenue
$103.0k
Current Earnings
-$51.8M
Current Profit Margin
-50,336.9%

CKPT Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when CKPT announces earnings.

CKPT Return on Assets

Current Company
-950%
Current Industry
2.9%
CKPT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CKPT Return on Capital Employed

Current Company
397.39%
Current Industry
19.5%
CKPT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CKPT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CKPT$103.00k-$51.85M-$51.85M-50.61%N/A
ABIO$0.00-$5.90M-$6.00MN/AN/A
ELDN$0.00-$39.95M-$40.33MN/AN/A
GANX$55.18k-$22.10M-$22.27M+21.77%N/A
GNTA$0.00-$12.28M-$12.66MN/AN/A
View Top Biotech Stocks

CKPT earnings dates

Next earnings date
May 13, 2024

Checkpoint Therapeutics Earnings & Revenue FAQ

What were CKPT's earnings last quarter?

On Invalid Date, Checkpoint Therapeutics (NASDAQ: CKPT) reported Q4 2023 earnings per share (EPS) of -$1.10, up 52.38% year over year. Total Checkpoint Therapeutics earnings for the quarter were -$19.13 million. In the same quarter last year, Checkpoint Therapeutics's earnings per share (EPS) was -$2.31.

If you're new to stock investing, here's how to buy Checkpoint Therapeutics stock.

What was CKPT's earnings growth in the past year?

As of Q2 2024, Checkpoint Therapeutics's earnings has grown year over year. Checkpoint Therapeutics's earnings in the past year totalled -$51.85 million.

What is CKPT's earnings date?

Checkpoint Therapeutics's earnings date is Invalid Date. Add CKPT to your watchlist to be reminded of CKPT's next earnings announcement.

What was CKPT's revenue last quarter?

On Invalid Date, Checkpoint Therapeutics (NASDAQ: CKPT) reported Q4 2023 revenue of $6.00 thousand up 91.89% year over year. In the same quarter last year, Checkpoint Therapeutics's revenue was $74.00 thousand.

What was CKPT's revenue growth in the past year?

As of Q2 2024, Checkpoint Therapeutics's revenue has grown -46.35% year over year. This is 192.09 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Checkpoint Therapeutics's revenue in the past year totalled $103.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.